Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 19 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0,5 mg Fingolimod (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬1. 0,5 mg Fingolimod
| [1] S1PR1 S1PR1 💬1. 0,5 mg Fingolimod
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬1. 0,5 mg Fingolimod
| ||||||||||||
| 2 | FINGOLIMOD (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬2. FINGOLIMOD
| [1] S1PR1 S1PR1 💬2. FINGOLIMOD
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [3] 13 13, 14, 156 💬
| ||||||||||||
| 3 | Fingolimod (FTY720) (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬3. Fingolimod (FTY720)
| [1] S1PR1 S1PR1 💬3. Fingolimod (FTY720)
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [2] 13 13, 156 💬
| ||||||||||||
| 4 | Fingolimod 0.5 mg (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬4. Fingolimod 0.5 mg
| [1] S1PR1 S1PR1 💬4. Fingolimod 0.5 mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬4. Fingolimod 0.5 mg
| ||||||||||||
| 5 | Fingolimod 0.5mg (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬5. Fingolimod 0.5mg
| [1] S1PR1 S1PR1 💬5. Fingolimod 0.5mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬5. Fingolimod 0.5mg
| ||||||||||||
| 6 | Fingolimod 1.25 mg (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬6. Fingolimod 1.25 mg
| [1] S1PR1 S1PR1 💬6. Fingolimod 1.25 mg
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬6. Fingolimod 1.25 mg
| ||||||||||||
| 7 | FINGOLIMOD HYDROCHLORIDE (Gilenya) | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬7. FINGOLIMOD HYDROCHLORIDE
| [1] S1PR1 S1PR1 💬7. FINGOLIMOD HYDROCHLORIDE
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [2] 13 13, 14 💬
| ||||||||||||
| 8 | Gilenya | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬8. Gilenya
| [1] S1PR1 S1PR1 💬8. Gilenya
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [3] 2 2, 13, 14 💬
| ||||||||||||
| 9 | GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬9. GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE
| [1] S1PR1 S1PR1 💬9. GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬9. GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE
| ||||||||||||
| 10 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE | [1] Fingolimod Fingolimod (Gilenya) | [1] Fingolimod
Fingolimod
(Gilenya) 💬10. GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE
| [1] S1PR1 S1PR1 💬10. GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE
| [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | [1] 13 13 💬10. GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE
|